ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


Trial of Eculizumab for HUS approved

26th December 2015

The trial for the drug Eculizumab for HUS sufferers has been approved. The study is known as the ECUSTEC. The drug is currently being used by aHUS sufferers. The Charity welcomes the trial which will start in 2016 as it is hoped that it will help improve the outcome for sufferers of HUS. To date there has been no specific treatment.

The Charity is one of the co-applicants for the drug based on the fact that there has been no such treatments previously. Whilst only time will tell whether or not the drug will work, we can only hope that it will be beneficial long term for such sufferers. The trial will take several years to complete.




Page
1 of 48
Next > Last >>

5th July 2024

Confirmed cases rise again to 288 in STEC O145 outbreak (Shiga toxin-producing Escherichia coli) from what is thought to have been caused from salad leaves (lettuce) in sandwiches and wraps. ... ...read on
27th June 2024

The UK Health Security Agency (UKHSA) stated in their press release of today 27... ...read on
21st June 2024

According to an update yesterday the 20th June 2024 from the  UK Health Security Agency (UKHSA) ,the number of confirmed ... ...read on
14th June 2024

Two suppliers of Supermarket sandwiches and wraps recall products as a precaution after E.coli O145 (Shiga toxin-producing Escherichia coli often referred to as ... ...read on
6th June 2024

The UK Health Security Agency (UKHSA) has advised of a large outbreak of Shiga toxin-producing Escherichia coli (STEC) O145, that currently appears to be spreading across the UK. This follow... ...read on
Page
1 of 48
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy